The Facts Are
A simple blood test is highly effective in detecting the levels of prostate-specific antigen (PSA) in a man’s bloodstream. Yet many physicians still suggest that the test is not 100% accurate and therefore not necessary. Few male patients will insist on it. Often overlooked is the simple fact that many serious diseases including prostate cancer show… Read More »
Tagged with: PSA, PSA Testing
Stopping Prostate Cancer
Researchers from Massachusetts General Harvard, Dana Farber Cancer Institute and Brigham and Women’s Hospital recently revealed that long-term use of aspirin is associated with lower risk of dying from various types of cancers, including lung and prostate cancer. Both cancers are the leading killers of men. The findings were presented… Read More »
A simple blood test using a single drop of blood is significantly more accurate than current screening methods. The new test will allow men to bypass invasive procedures to look for aggressive prostate cancer
The new Extracellular Vesicle Fingerprint Predictive Score (EV-FPS) test uses a computer to combine information from millions of cancer cell nanoparticles in the… Read More »
Men who take aspirin regularly may have a lower risk of dying from prostate cancer, a new study suggests.
Dr. Christopher Allard, a urologic oncology fellow at Harvard Medical School in Boston reported that the regular intake of aspirin decreases the risk of prostate cancer death by almost 40%. That may suggest men could have one more reason to consider regular aspirin use.
The findings were presented Jan.
Prostate cancer screening with prostate-specific antigen (PSA) has been shown to reduce death and the spread of prostate cancer to other parts of the body, but the PSA test remains highly controversial as it frequently leads to over diagnosis and over treatment of men who may not be at risk. Smarter screening strategies that can improve the accuracy of diagnosing lethal prostate cancer are urgently needed. Through a prospective… Read More »
Many studies have shown the negative effect health providers’ underlying prejudices can have on the doctor-patient relationship and the decisions patients make about their care. And according to a new study, oncologists are not immune.
Some cancer physicians are letting their implicit racial biases get in the way of quality treatment for Black patients.
Researchers at the Karmanos Cancer Institute in Detroit, Michigan, studied video-recorded interactions between 18… Read More »
Tagged with: Bayer, black patients, diet and prostate cancer, Harvard Medical School, JAMA Oncology, Journal of Clinical Oncology, Karmanos Cancer Institute, Louis A. Penner, men who speak up, Office of Minority Health, Quoc-Dien Trinh, real men get tested, Reuters, University of Colorado Cancer Center, ZERO
Men who have prostate cancer could reduce their risk of death by up to a third by eating nuts regularly, new research has suggested.
The researchers, experts at Harvard Medical School in Boston, studied 47,000 men over 26 years and identified 6,800 who had developed prostate cancer.
Writing in the British Journal of Cancer they found no “statistically significant associations” between eating nuts and being diagnosed with prostate cancer.
However,… Read More »
By: First Lady Frances Wolf
Tom and I announced this morning that Tom has been diagnosed with a treatable form of prostate cancer
Tom’s doctors made the diagnosis after a regular checkup revealed abnormalities.
We are very thankful that Tom’s doctors caught this cancer quickly and have worked to plan a treatment schedule that will address his medical issues and allow him to serve the people of Pennsylvania.
You… Read More »
